Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2003-11-25 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BOURGES (18000), Cher
SELARL PHARMACIE BERRICHONNE GAY ET GAY : revenue, balance sheet and financial ratios
SELARL PHARMACIE BERRICHONNE GAY ET GAY is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BOURGES (18000),
this company of category PME
shows in 2019 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE BERRICHONNE GAY ET GAY (SIREN 451109250)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
1 754 896 €
1 557 051 €
1 468 920 €
N/C
Net income
179 873 €
141 825 €
236 464 €
236 399 €
102 964 €
55 079 €
42 008 €
41 296 €
38 588 €
EBITDA
N/C
N/C
N/C
N/C
N/C
75 078 €
58 363 €
51 305 €
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
3.1%
2.7%
2.8%
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE BERRICHONNE GAY ET GAY generates positive net income of 180 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 39 k€ -> 180 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
179 873 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 9%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
8.987%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
73.792%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE BERRICHONNE GAY ET GAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
15.804
10.186
12.264
14.834
5.845
6.307
9.168
4.999
8.987
Financial autonomy
68.999
72.063
72.89
69.113
70.077
69.215
69.801
70.969
73.792
Repayment capacity
None
1.277
1.508
1.597
None
None
None
None
None
Cash flow / Revenue
None%
3.995%
3.804%
3.885%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
8.992024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE BERRICHO... (8.99) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
73.79%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of SELARL PHARMACIE BERRICHO... (73.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 358.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
358.699
Liquidity indicators evolution SELARL PHARMACIE BERRICHONNE GAY ET GAY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
235.3
237.743
266.1
252.981
215.504
244.494
268.553
265.422
358.699
Interest coverage
None
1.653
1.078
0.996
None
None
None
None
None
Sector positioning
Liquidity ratio
358.72024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of SELARL PHARMACIE BERRICHO... (358.70) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE BERRICHONNE GAY ET GAY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
273 293 €
304 793 €
261 971 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
43
39
39
0
0
0
0
0
Customer payment term (days)
0
6
7
3
0
0
0
0
0
Supplier payment term (days)
0
54
48
47
0
0
0
0
0
Positioning of SELARL PHARMACIE BERRICHONNE GAY ET GAY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE BERRICHONNE GAY ET GAY is estimated at
2 511 160 €
(range 1 748 732€ - 3 756 839€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1748k€2511k€3756k€
2 511 160 €Range: 1 748 732€ - 3 756 839€
NAF 5 année 2024
Valuation method used
Net Income Multiple
179 873 €
×
14.0x
=2 511 160 €
Range: 1 748 732€ - 3 756 839€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE BERRICHONNE GAY ET GAY with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE BERRICHONNE GAY ET GAY
What is the revenue of SELARL PHARMACIE BERRICHONNE GAY ET GAY ?
The revenue of SELARL PHARMACIE BERRICHONNE GAY ET GAY in 2019 is 1.8 M€.
Is SELARL PHARMACIE BERRICHONNE GAY ET GAY profitable?
Yes, SELARL PHARMACIE BERRICHONNE GAY ET GAY generated a net profit of 180 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE BERRICHONNE GAY ET GAY ?
The headquarters of SELARL PHARMACIE BERRICHONNE GAY ET GAY is located in BOURGES (18000), in the department Cher.
Where to find the tax return of SELARL PHARMACIE BERRICHONNE GAY ET GAY ?
The tax return of SELARL PHARMACIE BERRICHONNE GAY ET GAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE BERRICHONNE GAY ET GAY operate?
SELARL PHARMACIE BERRICHONNE GAY ET GAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart